ONCOGENE LMO1 AS A NOVEL DIFFERENTIATION AND PROGNOSTIC MARKER FOR NEUROENDOCRINE LUNG CANCERS

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Du,Liqin

Funded by

PETER BRADLEY CARLSON CHARITABLE TRUST

Research Start Date

01/01/2017

Status

Inactive

Basic Research

Cancer

Bioscience Research Panel